《大行》里昂:美國法院裁定對等關稅違法有利蘋果供應商 包括瑞聲(02018.HK)高偉(01415.HK)比亞迪電子(00285.HK)舜宇(02382.HK)等
里昂研究報告指,美國國際貿易法院裁定美國總統特朗普援引緊急法案所推出對等關稅屬違法,法院已下令立即暫停有爭議的關稅。雖然特朗普已即時上訴,但在上訴過程中,法院指令仍然有效。里昂認為有關措施將對蘋果(AAPL.US)的供應商有利,包括瑞聲科技(02018.HK)、高偉電子(01415.HK)、比亞迪電子(00285.HK)及舜宇光學科技(02382.HK)等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.